期刊选题

1、投稿方式：在线投稿。

2、官网网址：https://academic.oup.com/rb

3、投稿网址：http://mc.manuscriptcentral.com/rb

4、主办单位网址：

http://csbm.org.cn/article/articleinfo.asp?id=24

5、官网邮箱：info2@csbm.org.cn

lldew@qq.com

6、出刊日期：双月刊，逢单月出版。

7、微信公众号：

Regenerative Biomaterials（RB_JOURNAL）

2021年9月2日星期四

《再生生物材料（英文）》期刊介绍

【微信公众号“Regenerative Biomaterials”信息】

Regenerative Biomaterials 2021-07-12

中国生物材料学会会刊《再生生物材料（英文）》（Regenerative Biomaterials，Online ISSN 2056-3426， Print ISSN 2056-3418， CN 51-1798）是中国生物材料学会和牛津大学出版社合作出版的国际英文学术期刊，于2014年创刊。会刊编委会由70余位国内外知名专家和学者组成，中国生物材料学会名誉理事长、四川大学张兴栋院士和美国德州大学奥斯汀分校Nicholas Peppas院士担任会刊共同主编。

会刊被SCI-E、PubMed Central和DOAJ等数据库收录。2019年入选“中国科技期刊卓越行动计划高起点新刊”。 最新公布的影响因子为6.353，在Web of Science生物材料学科中位于2区。根据2020年中科院文献情报中心分区表，会刊位于工程技术大类2区，小类生物材料2区。

欢迎广大读者登录会刊官网免费注册、订阅和投稿。

https://academic.oup.com/rb

Regenerative Biomaterials《再生生物材料（英文）》的主要范围包括但不局限于以下内容：

•Design, synthesis, and evaluation of biomaterials for tissue engineering and regenerative medicine

•Nanotechnologies and novel processing for preparing biomimetic scaffolds

•Interaction of biomaterial with cells, especially with stem cells

•Regenerative mechanisms of tissue by using biomaterials and/or stem cells

•Drug/gene delivery materials and methods

•Clinical applications of regenerative biomaterials

•Scientific bases of evaluation and quality control of biomedical materials

•Surface modification of biomaterials

•Safety assessment of biomedical materials

•Stem cells fate controlled by materials signals

•Improvement of implanted medical devices

•Biomechanics of biomaterials and devices

•Regenerative engineering

《再生生物材料（英文）》作者须知

【官网信息】

Instructions to authors

Scope of the journal

Regenerative

Biomaterials, the official journal of Chinese Society for Biomaterials

is a fully open access, peer-reviewed journal. This journal is online

only and aims to provide an international platform for researchers to

share new ideas and research results in the field of biomaterials,

especially the biomaterials in regenerative medicine. With its broad

scope from the fundamental science of biomaterials to their potential

clinical applications, the journal publishes high quality reviews,

original research articles, communications, and perspectives.

The scope of Regenerative Biomaterials includes, but not limited to:

Design, synthesis, and evaluation of biomaterials for tissue engineering and regenerative medicine

Nanotechnologies and novel processing for preparing biomimetic scaffolds

Interaction of biomaterial with cells, especially with stem cells

Regenerative mechanisms of tissue by using biomaterials and/or stem cells

Drug/gene delivery materials and methods

Clinical applications of regenerative biomaterials

Scientific bases of evaluation and quality control of biomedical materials

Surface modification of biomaterials

Safety assessment of biomedical materials

Stem cells fate controlled by materials signals

Improvement of implanted medical devices

Biomechanics of biomaterials and devices

Regenerative engineering

Publication ethics

Authors

should observe high standards with respect to publication ethics as set

out by the Commission on Publication Ethics (COPE). Falsification or

fabrication of data, plagiarism, including duplicate publication of the

authors’ own work without proper citation, and misappropriation of the

work are all unacceptable practices. Any cases of ethical misconduct are

treated very seriously and will be dealt with in accordance with the

COPE guidelines.

Authorship

All

authors should have been involved in the writing of the manuscript at

draft and any revision stages, and have read and approved the final

version. Anyone who made major contributions to the writing of the

manuscript should be listed as an author (e.g. “ghost

writing” is prohibited by the Journal). Any other individuals who made

less substantive contributions to the study or the writing of the

manuscript should be listed in the acknowledgement section. Any change

in authorship (including author order) after the initial manuscript

submission must be approved in writing by all authors.

Authorship and 'Umbrella' groups

Many

large collaborative studies are organized under a group name which

represents all the participants. All articles must have at least one

named individual as author. Authors who wish to acknowledge the umbrella

group from which the data originate should first list the author(s) of

the article and follow this with 'on behalf of the GROUP NAME'. If

necessary the names of the participants may be listed in the

Acknowledgements section.

Originality

By

submitting your manuscript to the journal it is understood that this it

is an original manuscript and is unpublished work and is not under

consideration elsewhere. Plagiarism, including duplicate publication of

the author’s own work, in whole or in part without proper citation is

not tolerated by the journal. Manuscripts submitted to the journal may

be checked for originality using anti-plagiarism software.

Conflicts of interest

At

the point of submission, each author should reveal any financial

interests or connections, direct or indirect, or other situations that

might raise the question of bias in the work reported or the

conclusions, implications, or opinions stated – including pertinent

commercial or other sources of funding for the individual author(s) or

for the associated department(s) or organization(s), personal

relationships, or direct academic competition. When considering whether

you should declare a conflicting interest or connection please consider

the conflict of interest test: Is there any arrangement that would

embarrass you or any of your co-authors if it was to emerge after

publication and you had not declared it?

Experimental ethics

Animal experiments

When

reporting animal experiments authors should indicate whether the

institution’s, national research council’s, or any other law on the care

and use of laboratory animals was followed.

Human subjects

When

reporting on human subjects, authors should indicate whether the

procedures followed were in accordance with the ethical standards of the

Helsinki Declaration (1964, amended most recently in 2008) of the World

Medical Association. Manuscripts should include a statement that the

patient’s written consent was obtained and any information, including

illustrations, should be as anonymized as far as possible. Authors

should indicate that the design of the work has been approved by local

ethical committees or that it conforms to standards currently applied in

the country of origin. The name of the authorizing body should be

stated in the paper.

Peer review process

All

submissions to the journal are initially reviewed by one of the

Editors. At this stage manuscripts may be rejected without peer review

if it is felt that they are not of high enough priority or not relevant

to the journal. This fast rejection process means that authors are given

a quick decision and do not need to wait for the review process.

Manuscripts

that are not instantly rejected are sent out for peer review, usually

to two independent reviewers. Based on the feedback from these reviewers

and the Editors’ judgment a decision is given on the manuscript. The

average time from submission to first decision is 6 weeks.

If a paper is not acceptable in its present form, we will pass on suggestions for revisions to the author.

Material disclaimer

The

opinions expressed in Regenerative Biomaterials are those of the

authors and contributors, and do not necessarily reflect those of the

editors, the editorial board, Oxford University Press or the

organization to which the authors are affiliated.

……

更多详情：

https://academic.oup.com/rb/pages/General_Instructions